Nationwide survey on acute heart failure in cardiology ward services in Italy.
暂无分享,去创建一个
L. Tavazzi | A. Maggioni | F. Oliva | G. Cacciatore | M. Porcu | G. Ansalone | D. Lucci
[1] Paula Finn,et al. American Heart Association--scientific sessions 2005. 13-16 November 2005, Dallas, TX, USA. , 2006, IDrugs : the investigational drugs journal.
[2] R. Goldberg,et al. Incidence and hospital death rates associated with heart failure: a community-wide perspective. , 2005, The American journal of medicine.
[3] M. Nieminen,et al. Acute heart failure: Clinical presentation, one‐year mortality and prognostic factors , 2005, European journal of heart failure.
[4] Dario Gregori,et al. Temporal trends in survival and hospitalizations in outpatients with chronic systolic heart failure in 1995 and 1999. , 2005, Journal of cardiac failure.
[5] V. Hasselblad,et al. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. , 2005, Journal of cardiac failure.
[6] K. Adams,et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.
[7] K. Dickstein,et al. [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[8] L. Tavazzi,et al. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n‐3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure , 2004, European journal of heart failure.
[9] V. Hasselblad,et al. Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). , 2004, The American journal of cardiology.
[10] N. Freemantle,et al. Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure , 2004, European journal of heart failure.
[11] Peter C Austin,et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. , 2003, JAMA.
[12] L. Tavazzi,et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study. , 2003, American heart journal.
[13] N. Freemantle,et al. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. , 2003, European heart journal.
[14] N. Freemantle,et al. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .
[15] N Freemantle,et al. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.
[16] L. Tavazzi,et al. Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials: the BRING-UP experience , 2003, Heart.
[17] C. O'connor,et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. , 2003, American heart journal.
[18] M. Gheorghiade,et al. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. , 2003, American heart journal.
[19] T. LeJemtel,et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. , 2002, American heart journal.
[20] J. Cleland,et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial , 2002, The Lancet.
[21] Z. Vered,et al. Acute heart failure: a novel approach to its pathogenesis and treatment , 2002, European journal of heart failure.
[22] E. Perna,et al. Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema. , 2002, American heart journal.
[23] K. Swedberg,et al. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology , 2002, European journal of heart failure.
[24] J. Papp,et al. STEERING COMMITTEE AND INVESTIGATORS OF THE LEVOSIMENDAN INFUSION VERSUS DOBUTAMINE (LIDO) STUDY. EFFICACY AND SAFETY OF INTRAVENOUS LEVOSIMENDAN COMPARED WITH DOBUTAMINE IN SEVERE LOWOUTPUT HEART FAILURE (THE LIDO STUDY): A RANDOMISED DOUBLEBLIND TRIAL , 2002 .
[25] K. Swedberg,et al. Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.
[26] K. Kataoka,et al. Persistently Increased Serum Concentrations of Cardiac Troponin T in Patients With Idiopathic Dilated Cardiomyopathy Are Predictive of Adverse Outcomes , 2001, Circulation.
[27] D. Rubin,et al. Small-sample degrees of freedom with multiple imputation , 1999 .
[28] J. Croft,et al. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. , 1999, American heart journal.
[29] Y. Moshkovitz,et al. Increased toxicity of high‐dose furosemide versus low‐dose dopamine in the treatment of refractory congestive heart failure , 1997, Clinical pharmacology and therapeutics.
[30] M. Condorelli,et al. Inotropic stimulation by dobutamine increases left ventricular regional function at the expense of metabolism in hibernating myocardium. , 1996, American heart journal.